SCHEMBL314278

SCHEMBL314278

CCCCCCCCC=CCCCCCCCCC(O)C(O)CO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 6/20 0.53
CYP2D6 P10635 4/20 0.53
MAPT P10636 4/20 0.53
CETP P11597 4/20 0.53
GMNN O75496 3/20 0.53
LMNA P02545 3/20 0.53
POLB P06746 3/20 0.53
BLM P54132 3/20 0.53
UBE2N P61088 3/20 0.53
THPO P40225 2/20 0.53
TP53 P04637 2/20 0.53
CYP1A2 P05177 2/20 0.53
MTOR P42345 1/20 0.53
KDM4E B2RXH2 1/20 0.53
CYP3A4 P08684 1/20 0.53
HTT P42858 1/20 0.53
SPHK2 Q9NRA0 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
GLA P06280 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8574566 1.00 SPHK1 (0.53) SPHK1CYP2D6MAPTCETPGMNN
SCHEMBL27454783 1.00 SPHK1 (0.53) SPHK1CYP2D6MAPTCETPGMNN
SCHEMBL1962550 1.00 SPHK1 (0.53) SPHK1CYP2D6MAPTCETPGMNN
SCHEMBL2232599 1.00 SPHK1 (0.53) SPHK1CYP2D6MAPTCETPGMNN
SCHEMBL1963079 1.00 SPHK1 (0.53) SPHK1CYP2D6MAPTCETPGMNN
SCHEMBL1101078 1.00 SPHK1 (0.53) SPHK1CYP2D6MAPTCETPGMNN
SCHEMBL4619981 0.95 ALDH1A1 (0.53) LMNAKDM4ECYP3A4ALDH1A1ALOX15
SCHEMBL2710460 0.95 ALDH1A1 (0.53) LMNAKDM4ECYP3A4ALDH1A1ALOX15
SCHEMBL3992125 0.93 CNR1 (0.54) MAPTALDH1A1
SCHEMBL382168 0.93 CNR1 (0.54) MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110218250-A1 COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2011-09-08 US claimed
EP-1992327-A1 Composition based on glycerol ether/polyol mixtures Air Liquide Santé (International) (FR) 2008-11-19 EP claimed
EP-3204037-A1 COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME Rochal Industries, LLC (US) 2017-08-16 EP disclosed
WO-2016057788-A1 COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME ROCHAL INDUSTRIES, LLC (US) 2016-04-14 WO disclosed
US-8093193-B2 Composition based on glycerol ether/polyol mixtures AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2012-01-10 US disclosed
US-20110218250-A1 COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2011-09-08 US disclosed
US-20090326151-A1 HAIR COSMETIC KONISHI CO., LTD. (JP) 2009-12-31 US disclosed
EP-2039347-A1 COSMETIC HAIR PREPARATION Shiseido Company, Limited (JP) 2009-03-25 EP disclosed
EP-1992327-A1 Composition based on glycerol ether/polyol mixtures Air Liquide Santé (International) (FR) 2008-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218250-A1 COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES MGLL, DAGLA, DAGLB SPHK1 86/4885CYP2D6 1793/4885MAPT 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.